α-NETAA fluorescent choactase inhibitor

α-NETA (CAS 31059-54-8)

α-NETA | CAS 31059-54-8 is rated 5.0 out of 5 by 1.
  • y_2019, m_11, d_19, h_22
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.3-b1
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_221190, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 79ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Synonym: 2-naphthoylethyltrimethylammonium
Application: A fluorescent choactase inhibitor
CAS Number: 31059-54-8
Purity: ≥97%
Molecular Weight: 369.24
Molecular Formula: C16H20INO
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

α-NETA is a potent, fluorescent inhibitor of Choactase (choline acetyltransferase).


References

1. Sastry, B V., et al., 1988. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase. The Journal of pharmacology and experimental therapeutics. 245(1): 72-80. PMID: 3361452

Physical State :
Solid
Solubility :
Soluble in methanol.
Storage :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
PubChem CID :
11957648
MDL Number :
MFCD00209857
SMILES :
C[N+](C)(C)CCC(=O)C1=CC=CC2=CC=CC=C21.[I-]

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

α-NETA  Product Citations

See how others have used α-NETA. Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 29499303  Zhang, Y.|Xu, N.|Ding, Y.|Zhang, Y.|Li, Q.|Flores, J.|Haghighiabyaneh, M.|Doycheva, D.|Tang, J.|Zhang, JH.| et al. 2018. Brain Behav. Immun. 70: 179-193.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 55ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Eaton Eaton, et al. (PubMed ID 9859871) found that pre-incubation of their BeWo choriocarcinoma cells with -NETA reduced the choline maximal uptake by 77%. -SCBT Publication Review
Date published: 2015-01-25
  • y_2019, m_11, d_19, h_22
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.3-b1
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_221190, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 14ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.